507 related articles for article (PubMed ID: 27480833)
1. Vascular ADAM17 as a Novel Therapeutic Target in Mediating Cardiovascular Hypertrophy and Perivascular Fibrosis Induced by Angiotensin II.
Takayanagi T; Forrester SJ; Kawai T; Obama T; Tsuji T; Elliott KJ; Nuti E; Rossello A; Kwok HF; Scalia R; Rizzo V; Eguchi S
Hypertension; 2016 Oct; 68(4):949-955. PubMed ID: 27480833
[TBL] [Abstract][Full Text] [Related]
2. Role of epidermal growth factor receptor and endoplasmic reticulum stress in vascular remodeling induced by angiotensin II.
Takayanagi T; Kawai T; Forrester SJ; Obama T; Tsuji T; Fukuda Y; Elliott KJ; Tilley DG; Davisson RL; Park JY; Eguchi S
Hypertension; 2015 Jun; 65(6):1349-55. PubMed ID: 25916723
[TBL] [Abstract][Full Text] [Related]
3. DKK3 overexpression attenuates cardiac hypertrophy and fibrosis in an angiotensin-perfused animal model by regulating the ADAM17/ACE2 and GSK-3β/β-catenin pathways.
Zhai CG; Xu YY; Tie YY; Zhang Y; Chen WQ; Ji XP; Mao Y; Qiao L; Cheng J; Xu QB; Zhang C
J Mol Cell Cardiol; 2018 Jan; 114():243-252. PubMed ID: 29196099
[TBL] [Abstract][Full Text] [Related]
4. Caveolin-1 Deletion Prevents Hypertensive Vascular Remodeling Induced by Angiotensin II.
Forrester SJ; Elliott KJ; Kawai T; Obama T; Boyer MJ; Preston KJ; Yan Z; Eguchi S; Rizzo V
Hypertension; 2017 Jan; 69(1):79-86. PubMed ID: 27895190
[TBL] [Abstract][Full Text] [Related]
5. Vascular ADAM17 (a Disintegrin and Metalloproteinase Domain 17) Is Required for Angiotensin II/β-Aminopropionitrile-Induced Abdominal Aortic Aneurysm.
Kawai T; Takayanagi T; Forrester SJ; Preston KJ; Obama T; Tsuji T; Kobayashi T; Boyer MJ; Cooper HA; Kwok HF; Hashimoto T; Scalia R; Rizzo V; Eguchi S
Hypertension; 2017 Nov; 70(5):959-963. PubMed ID: 28947615
[TBL] [Abstract][Full Text] [Related]
6. Caveolin 1 is critical for abdominal aortic aneurysm formation induced by angiotensin II and inhibition of lysyl oxidase.
Takayanagi T; Crawford KJ; Kobayashi T; Obama T; Tsuji T; Elliott KJ; Hashimoto T; Rizzo V; Eguchi S
Clin Sci (Lond); 2014 Jun; 126(11):785-94. PubMed ID: 24329494
[TBL] [Abstract][Full Text] [Related]
7. Loss of smooth muscle cell disintegrin and metalloproteinase 17 transiently suppresses angiotensin II-induced hypertension and end-organ damage.
Shen M; Morton J; Davidge ST; Kassiri Z
J Mol Cell Cardiol; 2017 Feb; 103():11-21. PubMed ID: 27993561
[TBL] [Abstract][Full Text] [Related]
8. A Disintegrin and Metalloprotease-17 Regulates Pressure Overload-Induced Myocardial Hypertrophy and Dysfunction Through Proteolytic Processing of Integrin β1.
Fan D; Takawale A; Shen M; Samokhvalov V; Basu R; Patel V; Wang X; Fernandez-Patron C; Seubert JM; Oudit GY; Kassiri Z
Hypertension; 2016 Oct; 68(4):937-48. PubMed ID: 27550917
[TBL] [Abstract][Full Text] [Related]
9. The effects of different angiotensin II type 1 receptor blockers on the regulation of the ACE-AngII-AT1 and ACE2-Ang(1-7)-Mas axes in pressure overload-induced cardiac remodeling in male mice.
Wang X; Ye Y; Gong H; Wu J; Yuan J; Wang S; Yin P; Ding Z; Kang L; Jiang Q; Zhang W; Li Y; Ge J; Zou Y
J Mol Cell Cardiol; 2016 Aug; 97():180-90. PubMed ID: 27210827
[TBL] [Abstract][Full Text] [Related]
10. Kaempferol Alleviates Angiotensin II-Induced Cardiac Dysfunction and Interstitial Fibrosis in Mice.
Liu Y; Gao L; Guo S; Liu Y; Zhao X; Li R; Yan X; Li Y; Wang S; Niu X; Yao L; Zhang Y; Li L; Yang H
Cell Physiol Biochem; 2017; 43(6):2253-2263. PubMed ID: 29073623
[TBL] [Abstract][Full Text] [Related]
11. Angiotensin II Type 1A Receptor Expressed in Smooth Muscle Cells is Required for Hypertensive Vascular Remodeling in Mice Infused With Angiotensin II.
Okuno K; Torimoto K; Cicalese SM; Preston K; Rizzo V; Hashimoto T; Coffman TM; Sparks MA; Eguchi S
Hypertension; 2023 Mar; 80(3):668-677. PubMed ID: 36628961
[TBL] [Abstract][Full Text] [Related]
12. Ursolic acid prevents angiotensin II-induced abdominal aortic aneurysm in apolipoprotein E-knockout mice.
Zhai M; Guo J; Ma H; Shi W; Jou D; Yan D; Liu T; Tao J; Duan J; Wang Y; Li S; Lv J; Li C; Lin J; Zhang C; Lin L
Atherosclerosis; 2018 Apr; 271():128-135. PubMed ID: 29499360
[TBL] [Abstract][Full Text] [Related]
13. Epidermal growth factor receptor is critical for angiotensin II-mediated hypertrophy in cerebral arterioles.
Chan SL; Umesalma S; Baumbach GL
Hypertension; 2015 Apr; 65(4):806-12. PubMed ID: 25733240
[TBL] [Abstract][Full Text] [Related]
14. Overexpressed connective tissue growth factor in cardiomyocytes attenuates left ventricular remodeling induced by angiotensin II perfusion.
Zhang Y; Yan H; Guang GC; Deng ZR
Clin Exp Hypertens; 2017; 39(2):168-174. PubMed ID: 28287886
[TBL] [Abstract][Full Text] [Related]
15. Cardioprotective effects of granulocyte colony-stimulating factor in angiotensin II-induced cardiac remodelling.
Jia N; Dong P; Huang Q; Jin W; Zhang J; Dai Q; Liu S
Clin Exp Pharmacol Physiol; 2009 Mar; 36(3):262-6. PubMed ID: 18785976
[TBL] [Abstract][Full Text] [Related]
16. Caveolin-1 negatively regulates a metalloprotease-dependent epidermal growth factor receptor transactivation by angiotensin II.
Takaguri A; Shirai H; Kimura K; Hinoki A; Eguchi K; Carlile-Klusacek M; Yang B; Rizzo V; Eguchi S
J Mol Cell Cardiol; 2011 Mar; 50(3):545-51. PubMed ID: 21172357
[TBL] [Abstract][Full Text] [Related]
17. Antagonist of C5aR prevents cardiac remodeling in angiotensin II-induced hypertension.
Zhang C; Li Y; Wang C; Wu Y; Du J
Am J Hypertens; 2014 Jun; 27(6):857-64. PubMed ID: 24419904
[TBL] [Abstract][Full Text] [Related]
18. Endoplasmic Reticulum Chemical Chaperone 3-Hydroxy-2-Naphthoic Acid Reduces Angiotensin II-Induced Vascular Remodeling and Hypertension In Vivo and Protein Synthesis In Vitro.
Cicalese S; Torimoto K; Okuno K; Elliott KJ; Rizzo V; Hashimoto T; Eguchi S
J Am Heart Assoc; 2022 Dec; 11(23):e028201. PubMed ID: 36444851
[TBL] [Abstract][Full Text] [Related]
19. Targeting the calpain/calpastatin system as a new strategy to prevent cardiovascular remodeling in angiotensin II-induced hypertension.
Letavernier E; Perez J; Bellocq A; Mesnard L; de Castro Keller A; Haymann JP; Baud L
Circ Res; 2008 Mar; 102(6):720-8. PubMed ID: 18258859
[TBL] [Abstract][Full Text] [Related]
20. Upregulation of Nox4 promotes angiotensin II-induced epidermal growth factor receptor activation and subsequent cardiac hypertrophy by increasing ADAM17 expression.
Zeng SY; Chen X; Chen SR; Li Q; Wang YH; Zou J; Cao WW; Luo JN; Gao H; Liu PQ
Can J Cardiol; 2013 Oct; 29(10):1310-9. PubMed ID: 23850346
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
